Next Quarterly Earnings
Wednesday, November 11, 2026
CW 46
After-Hours
In 76 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Arcturus Therapeutics
Arcturus Therapeutics is a US-based biotechnology company specializing in the development of innovative mRNA therapeutics. Utilizing its proprietary LUNAR platform, the company researches novel RNA medicines and vaccines. Its focus is on transformative therapies for rare and infectious diseases, aiming to address significant unmet medical needs.
Frequently asked questions
When will Arcturus Therapeutics report its next quarterly earnings?
Arcturus Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Arcturus Therapeutics last report quarterly earnings?
Arcturus Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.84 USD.
How does Arcturus Therapeutics stock react to earnings?
Across its last 3 earnings reports, Arcturus Therapeutics stock moved by ±3% on average the following day. The largest reaction was -4.2% on 03/03/2026; 1 of 3 reactions were positive.
How often has Arcturus Therapeutics beaten expectations?
Arcturus Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Arcturus Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±3%
Avg. next-day move
-4.2%
Largest move (03/03/2026)
33.3%
Share of positive reactions
±12.9%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
-1.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Arcturus Therapeutics
Country
🇺🇸
More Financial Information